Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths

Vikas Prasad; Lisa Bodei; Mark Kidd; Irvin M. Modlin

doi:10.1007/s00259-014-2780-0

Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths

Vikas Prasad
, Lisa Bodei
, Mark Kidd
, Irvin M. Modlin

Division of Nuclear Medicine

Research output: Contribution to journal › Editorial

7 Scopus citations

Original language	English
Pages (from-to)	1825-1830
Number of pages	6
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	41
Issue number	10
DOIs	https://doi.org/10.1007/s00259-014-2780-0
State	Published - Oct 2014

Access to Document

10.1007/s00259-014-2780-0

Cite this

@article{48188454897c4714abf9a7f88b2d871c,

title = "Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths",

author = "Vikas Prasad and Lisa Bodei and Mark Kidd and Modlin, \{Irvin M.\}",

year = "2014",

month = oct,

doi = "10.1007/s00259-014-2780-0",

language = "English",

volume = "41",

pages = "1825--1830",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

number = "10",

}

TY - JOUR

T1 - Whither peptide receptor radionuclide therapy for neuroendocrine tumors

T2 - an Einsteinian view of the facts and myths

AU - Prasad, Vikas

AU - Bodei, Lisa

AU - Kidd, Mark

AU - Modlin, Irvin M.

PY - 2014/10

Y1 - 2014/10

UR - https://www.scopus.com/pages/publications/84930723725

U2 - 10.1007/s00259-014-2780-0

DO - 10.1007/s00259-014-2780-0

M3 - Editorial

C2 - 24806111

AN - SCOPUS:84930723725

SN - 1619-7070

VL - 41

SP - 1825

EP - 1830

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 10

ER -

Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths

Access to Document

Other files and links

Cite this